These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3764379)

  • 21. Agranulocytosis coincident with amodiaquine therapy.
    Booth K; Larkin K; Maddocks I
    Br Med J; 1967 Jul; 3(5556):32-3. PubMed ID: 6027382
    [No Abstract]   [Full Text] [Related]  

  • 22. [Agranulocytosis and toxic hepatitis in patients treated with Favistan].
    Manojlović D; Nesović M; Mićić J; Djurić D
    Srp Arh Celok Lek; 1977 Jun; 105(6):549-54. PubMed ID: 607474
    [No Abstract]   [Full Text] [Related]  

  • 23. Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro.
    Lind DE; Levi JA; Vincent PC
    Br Med J; 1973 Feb; 1(5851):458-60. PubMed ID: 4689836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Propylthiouracil-induced hepatitis and agranulocytosis].
    Nielsen HK; Iversen TO
    Ugeskr Laeger; 1980 Nov; 142(48):3189-90. PubMed ID: 7445231
    [No Abstract]   [Full Text] [Related]  

  • 25. Leucopenia and abnormal liver function in travellers on malaria chemoprophylaxis.
    Stürchler D; Schär M; Gyr N
    J Trop Med Hyg; 1987 Oct; 90(5):239-43. PubMed ID: 3669125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenytoin induced severe agranulocytosis and hepatitis.
    Kakar A; Byotra SP
    J Assoc Physicians India; 1999 Jun; 47(6):644. PubMed ID: 10999171
    [No Abstract]   [Full Text] [Related]  

  • 27. [Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism].
    Frenkel J; Téllez R; Reyes C; González G; Michaud P
    Rev Med Chil; 1993 Nov; 121(11):1289-94. PubMed ID: 8191137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of hematologic side effects of anti-infective therapy: agranulocytosis caused by beta-lactam antibiotics, vancomycin and amodiaquine].
    Eich G; Neftel KA
    Infection; 1991; 19 Suppl 1():S33-7. PubMed ID: 2007513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agranulocytosis and hepatitis as a result of Mexican drug therapy.
    Jacknowitz AI; Walker BK
    Drug Intell Clin Pharm; 1984 Jan; 18(1):66-8. PubMed ID: 6692743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients.
    Metushi IG; Hayes MA; Uetrecht J
    Hepatology; 2015 Apr; 61(4):1332-42. PubMed ID: 25283142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parasitological and clinical response to amodiaquine versus chloroquine in the treatment of Plasmodium falciparum malaria in children in an endemic area].
    Penali LK; Assi-Coulibaly L; Kaptué B; Konan D; Ehouman A
    Bull Soc Pathol Exot; 1994; 87(4):244-7. PubMed ID: 7866044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amodiaquine and hepatitis.
    Hirschel B
    Ann Intern Med; 1986 Sep; 105(3):467. PubMed ID: 3740693
    [No Abstract]   [Full Text] [Related]  

  • 33. Stomatitis, agranulocytosis and hepatits due to phenindione sensitivity.
    Gupta MC; Kumar S; Tyagi SP; Srivastava SS
    J Indian Med Assoc; 1974 Nov; 63(10):324-7. PubMed ID: 4452787
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
    Tagbor H; Bruce J; Browne E; Randal A; Greenwood B; Chandramohan D
    Lancet; 2006 Oct; 368(9544):1349-56. PubMed ID: 17046467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biotransformation of amiodaquine and prophylaxis of Plasmodium falciparum malaria].
    Pussard E; Verdier F; Blayo MC; Pocidalo JJ
    C R Acad Sci III; 1985; 301(8):383-5. PubMed ID: 3933781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of antimalarial prophylaxis.
    Markus MB
    S Afr Med J; 1986 Aug; 70(4):238. PubMed ID: 3738667
    [No Abstract]   [Full Text] [Related]  

  • 38. Intermittent preventive treatment with antimalarial drugs.
    Billal DS; Hotomi M; Yamanaka N
    Lancet; 2009 Jan; 373(9657):28-9; author reply 29. PubMed ID: 19121718
    [No Abstract]   [Full Text] [Related]  

  • 39. [Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
    Rabina EV; Semichastnova AG; Golubiatnikova GA
    Arkh Patol; 1972; 34(8):75-7. PubMed ID: 4345581
    [No Abstract]   [Full Text] [Related]  

  • 40. Can amodiaquine be used safely during pregnancy?
    Thomas F; Erhart A; D'Alessandro U
    Lancet Infect Dis; 2004 Apr; 4(4):235-9. PubMed ID: 15050942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.